Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Malaria Vaccines Market?

The scale of the malaria vaccines market has experienced significant expansion in recent years. It is projected to enlarge from $4.7 billion in 2024 to $6.24 billion in 2025, marking a compound annual growth rate (CAGR) of 32.7%. The growth during the historical period is due to factors such as the high burden of malaria, global health campaigns, financial aids and grants, malaria control initiatives, governmental backing and regulatory structures.

The market for malaria vaccines is anticipated to witness substantial growth in the upcoming years, reaching a valuation of $20.19 billion in 2029 with a CAGR of 34.1%. The predicted expansion during the forecast period can be credited to various factors such as widespread elimination goals, broadened access programs, escalating vaccine coverage, alliances on a global scale, and the influence of climate change. Technological breakthroughs, collaborations between public and private sectors, international cooperation, and advancements in vaccine technology are among the major trends during the forecast period.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13698&type=smp

Which Industry Forces Are Driving The Malaria Vaccines Market Forward?

The escalation in mosquito-borne illnesses is anticipated to fuel the expansion of the malaria vaccine market in the future. These diseases encompass a wide range of conditions transmitted through the bite of an infected mosquito. The malaria vaccine, especially the RTS, S/AS01 (RTS, S) formulation, is employed to mitigate the effects of these mosquito-transmitted infectious diseases, as it trains the immune system to identify and combat the parasite. For instance, a report published by the World Health Organization, a Switzerland-based intergovernmental association, in November 2023 stated that an estimated 249 million instances of malaria were reported globally in 2022, marking an increase of 5 million cases from 2021. Additionally, Pakistan recorded a significant rise from 500,000 cases in 2021 to about 2.6 million cases in 2022. Consequently, the surge in the prevalence of mosquito-borne diseases is contributing to the development of the malaria vaccine market.

How Is The Malaria Vaccines Market Organized By Different Segments?

The malaria vaccinesmarket covered in this report is segmented –

1) By Agent: Plasmodium Falciparum; Plasmodium Vivax; Anopheles Species

2) By Vaccine Type: Pre-Erythrocytic; Erythrocytic; Multi-antigen; Other Vaccines

3) By Route Of Administration: Intramuscular; Subcutaneous; Intradermal; Other Routes

4) By Distribution Channel: Public; Private

Subsegments:

1) By Plasmodium Falciparum: RTS,S/AS01 Vaccine; Other Experimental Vaccines

2) By Plasmodium Vivax: Candidate Vaccines In Development; Combination Vaccines

3) By Anopheles Species: Transmission-Blocking Vaccines; Vector Control Approaches

What Current And Upcoming Trends Are Shaping The Malaria Vaccines Market?

Leading corporations in the malaria vaccine market are creating unique offerings like children’s malaria vaccines as a way to reach a broader consumer base, drive sales, and boost their revenue. These vaccines for mosquito-transmitted diseases are immunological concoctions designed to defend against such diseases. A pediatric vaccine has been developed for Plasmodium falciparum, the world’s deadliest malaria parasite, which is most common in Africa. For example, in November 2022, Malawi, an East African country, and the World Health Organization, a Swiss-based intergovernmental body, introduced the first malaria vaccine for children in Africa. The unique feature of the RTSS vaccine, specifically crafted for young children, is its potential to cut down the mortality rate from this mosquito-transmitted disease. Despite a modest success rate of 30% after pilot testing on over one million children in Ghana, Kenya, and Malawi, the vaccine has kindled hope that it could save the lives of the 400,000 people who die from malaria every year.

Who Are The Primary Market Leaders In The Malaria Vaccines Market?

Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/malaria-vaccines-global-market-report

How Do Regional Dynamics Influence The Malaria Vaccines Market Performance?

North America was the largest region in the malaria vaccines market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13698&type=smp

Browse Through More Reports Similar to the Global Malaria Vaccines Market 2025, By The Business Research Company

Inactivated Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Dog Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model